HC Wainwright & Co. analyst Raghuram Selvaraju maintains Fennec Pharmaceuticals (NASDAQ:FENC) with a Buy and raises the price target from $14 to $18.
French Fashion Giant LVMH Records 3% Organic Revenue Growth In Q1: Details
LVMH-Moet Hennessy Louis Vuitton records €20.7 billion revenue in Q1 FY24, with organic growth at 3%. Despite a 2% decline, the Fashion & Leather Goods business group sees a 2% organic revenue increase, while the Perfumes & Cosmetics business group records 7% organic growth.
